Home > > > Tuberculosis Testing Technology Market to Reach USD 3.8 Billion by 2034 | CAGR 4.8%

Tuberculosis Testing Technology Market to Reach USD 3.8 Billion by 2034 | CAGR 4.8%

Author : shivani ghodake | Published On : 30 Sep 2026

According to a report by IntelMarketResearch, global Tuberculosis Testing Technology market was valued at USD 2.5 billion in 2025 and is projected to grow from USD 2.6 billion in 2026 to USD 3.8 billion by 2034, registering a CAGR of 4.8% during the forecast period. Market growth is being driven by the rising need for rapid and accurate TB diagnosis, increasing adoption of point-of-care molecular testing, demand for drug-resistance detection, and continued investment in diagnostic technologies across high-burden regions.

Explore the full report: https://www.intelmarketresearch.com/tuberculosis-testing-technology-market-63777

Why Is Demand Increasing

 

  • Rising TB Burden: Increasing tuberculosis incidence in high-risk regions is encouraging health systems to prioritize rapid diagnostic technologies that can support earlier case identification and treatment.
  • Point-of-Care Adoption: Portable molecular testing platforms are expanding access to rapid diagnostics in remote and decentralized healthcare settings where conventional laboratory infrastructure is limited.
  • Advanced Diagnostic Technologies: Molecular testing, AI-enabled imaging, digital connectivity, and drug-resistance detection are improving the speed and scope of tuberculosis diagnosis.

 

TB Diagnostics Watch: AI-Enabled and Decentralized Testing

The TB diagnostics landscape is shifting toward portable molecular platforms, AI-assisted chest-X-ray interpretation, and connected diagnostic systems. These technologies can help reduce diagnostic delays and extend testing capabilities to primary-care clinics, mobile screening units, and other settings outside centralized laboratories.

Download the free sample report: https://www.intelmarketresearch.com/download-free-sample/63777/tuberculosis-testing-technology-market

Segmentation Highlights

 

  • By Type: Molecular Tests and Immunological Tests, with molecular technologies benefiting from rapid turnaround and high analytical sensitivity.
  • By Application: Active TB Detection, Latent TB Infection Detection, Drug-Resistance Testing, Point-of-Care Testing, and Others.
  • By Technology: PCR-based Platforms, NGS-based Platforms, and Culture-based Methods, with PCR-based platforms increasingly favored for speed and operational simplicity.

 

Regional Outlook

 

  • Asia-Pacific: Represents the largest market in the base year and is supported by significant TB testing requirements, public-health programs, and expanding adoption of molecular diagnostics.
  • North America: Maintains a major market position through mature healthcare infrastructure, advanced diagnostic adoption, and continued investment in testing innovation.

 

Download the free sample report: https://www.intelmarketresearch.com/download-free-sample/63777/tuberculosis-testing-technology-market

Why This Market Matters

Tuberculosis testing technologies are essential for early detection, treatment planning, surveillance, and identification of drug-resistant infections. The increasing movement toward rapid molecular testing, decentralized diagnostics, AI-supported imaging, and digital data connectivity is creating opportunities for diagnostic manufacturers and healthcare systems seeking faster and more accessible TB testing.

Competitive Landscape

 

  • Cepheid: Provides GeneXpert molecular diagnostic systems widely used for rapid tuberculosis testing.
  • Abbott Laboratories: Offers infectious-disease diagnostic technologies and TB testing solutions.
  • Roche Diagnostics: Develops molecular testing platforms and assays for infectious diseases, including tuberculosis.
  • Siemens Healthineers: Provides laboratory and diagnostic technologies supporting infectious-disease testing.
  • Becton Dickinson: Supplies diagnostic platforms and technologies used across clinical and infectious-disease laboratories.

 

View the full report: https://www.intelmarketresearch.com/tuberculosis-testing-technology-market-63777

FAQ

What is the current size of the Tuberculosis Testing Technology market? The global market was valued at USD 2.5 billion in 2025.

What will the market be worth by 2034? The market is projected to reach USD 3.8 billion by 2034 at a CAGR of 4.8%.

What are the key growth drivers? Major drivers include rising TB incidence, point-of-care molecular testing, demand for rapid diagnostics, drug-resistance testing, and advances in AI-enabled diagnostic technologies.

What Does the Full Report Cover?

The full report provides comprehensive analysis of the global Tuberculosis Testing Technology market, including market size and forecasts, diagnostic types, applications, technologies, diagnostic settings, regional markets, competitive landscape, molecular testing developments, AI-enabled diagnostics, point-of-care platforms, market drivers, challenges, restraints, opportunities, and emerging trends.

View the complete report: https://www.intelmarketresearch.com/tuberculosis-testing-technology-market-63777

Download the free sample: https://www.intelmarketresearch.com/download-free-sample/63777/tuberculosis-testing-technology-market

Related Reports

 

 

About IntelMarketResearch

IntelMarketResearch provides market intelligence and industry research across technology, healthcare, industrial, chemicals, materials, energy, consumer goods, and other high-growth sectors. Its reports cover market sizing, segmentation, competitive landscapes, regional analysis, industry trends, technological developments, and forecasts.

Contact Details

IntelMarketResearch Email: [email protected] Phone: +91 9169164321 Website: https://www.intelmarketresearch.com Linkedin: Follow us